Cinda M. Boyer

1.8k total citations
31 papers, 1.5k citations indexed

About

Cinda M. Boyer is a scholar working on Immunology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Cinda M. Boyer has authored 31 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Immunology, 13 papers in Molecular Biology and 13 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Cinda M. Boyer's work include Monoclonal and Polyclonal Antibodies Research (13 papers), HER2/EGFR in Cancer Research (8 papers) and Immune Cell Function and Interaction (6 papers). Cinda M. Boyer is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (13 papers), HER2/EGFR in Cancer Research (8 papers) and Immune Cell Function and Interaction (6 papers). Cinda M. Boyer collaborates with scholars based in United States, Australia and Italy. Cinda M. Boyer's co-authors include Robert C. Bast, Ian F. C. McKenzie, Keith R. Jerome, Olivera J. Finn, Donna L. Barnd, Katharine M. Bendt, Joyce Taylor‐Papadimitriou, Janet Warner, Les Sekut and Paul J. Furdon and has published in prestigious journals such as Nature, Journal of Biological Chemistry and Cancer.

In The Last Decade

Cinda M. Boyer

30 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cinda M. Boyer United States 18 656 620 537 355 260 31 1.5k
Juan J. Roman United States 23 599 0.9× 568 0.9× 728 1.4× 208 0.6× 191 0.7× 27 1.8k
Ilana Yron Israel 20 789 1.2× 335 0.5× 432 0.8× 144 0.4× 131 0.5× 42 1.3k
R. Vilella Spain 26 790 1.2× 684 1.1× 354 0.7× 185 0.5× 88 0.3× 69 1.8k
Marialuisa Sensi Italy 27 1.8k 2.8× 1.4k 2.3× 1.1k 2.1× 186 0.5× 287 1.1× 92 2.9k
D J Panka United States 12 1.4k 2.1× 972 1.6× 278 0.5× 216 0.6× 233 0.9× 18 2.0k
Ricciarda Galandrini Italy 26 1.0k 1.6× 481 0.8× 416 0.8× 108 0.3× 56 0.2× 55 1.6k
L M Neckers United States 16 523 0.8× 940 1.5× 672 1.3× 138 0.4× 127 0.5× 24 1.8k
Giuliana Papoff Italy 15 796 1.2× 1.1k 1.8× 274 0.5× 107 0.3× 228 0.9× 28 1.9k
Y Tsujimoto United States 7 324 0.5× 944 1.5× 400 0.7× 103 0.3× 127 0.5× 8 1.5k
Luigi Scotto United States 30 1.1k 1.6× 1.5k 2.5× 642 1.2× 97 0.3× 280 1.1× 82 2.8k

Countries citing papers authored by Cinda M. Boyer

Since Specialization
Citations

This map shows the geographic impact of Cinda M. Boyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cinda M. Boyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cinda M. Boyer more than expected).

Fields of papers citing papers by Cinda M. Boyer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cinda M. Boyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cinda M. Boyer. The network helps show where Cinda M. Boyer may publish in the future.

Co-authorship network of co-authors of Cinda M. Boyer

This figure shows the co-authorship network connecting the top 25 collaborators of Cinda M. Boyer. A scholar is included among the top collaborators of Cinda M. Boyer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cinda M. Boyer. Cinda M. Boyer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Boyer, Cinda M., Lajos Pusztai, Jon R. Wiener, et al.. (1999). Relative cytotoxic activity of immunotoxins reactive with different epitopes on the extracellular domain of the c-erbB-2 (HER-2/neu) gene product p185. International Journal of Cancer. 82(4). 525–531. 21 indexed citations
4.
Bast, Robert C., Lajos Pusztai, Billie‐Jo Kerns, et al.. (1998). Coexpression of the HER-2 Gene Product, pl85 HER-2 , and Epidermal Growth Factor Receptor, pl70 EGF-R , on Epithelial Ovarian Cancers and Normal Tissues. Hybridoma. 17(4). 313–321. 32 indexed citations
5.
Orlandi, Rosaria, et al.. (1997). A Linear Region of a Monoclonal Antibody Conformational Epitope Mapped on p185HER2 Oncoprotein. Biological Chemistry. 378(11). 1387–92. 14 indexed citations
6.
Russell, Peter, Cinda M. Boyer, Billie‐Jo M. Kerns, et al.. (1996). Expression of cell regulatory proteins in ovarian borderline tumors. Cancer. 77(10). 2092–2098. 23 indexed citations
7.
8.
McGeehan, Gerard M., J. David Becherer, Robert C. Bast, et al.. (1994). Regulation of tumour necrosis factor-α processing by a metalloproteinase inhibitor. Nature. 370(6490). 558–561. 485 indexed citations
9.
Xu, Fengji, Ruth Lupu, Gustavo C. Rodriguez, et al.. (1993). Antibody‐induced growth inhibition is mediated through immunochemically and functionally distinct epitopes on the extracellular domain of the c‐erbb‐2 (her‐2/neu) gene product p185. International Journal of Cancer. 53(3). 401–408. 53 indexed citations
10.
Bast, Robert C., Cinda M. Boyer, Ian Jacobs, et al.. (1993). Cell growth regulation in epithelial ovarian cancer. Cancer. 71(S4). 1597–1601. 72 indexed citations
11.
Crews, Jennie R., Lisa A. Maier, Yu Yin, et al.. (1992). A combination of two immunotoxins exerts synergistic cytotoxic activity against human breast‐cancer cell lines. International Journal of Cancer. 51(5). 772–779. 14 indexed citations
12.
Olt, George J., et al.. (1992). Fibronectin is an immunosuppressive substance associated with epithelial ovarian cancer. Cancer. 70(8). 2137–2142. 6 indexed citations
13.
Jerome, Keith R., Donna L. Barnd, Katharine M. Bendt, et al.. (1991). Cytotoxic T-lymphocytes derived from patients with breast adenocarcinoma recognize an epitope present on the protein core of a mucin molecule preferentially expressed by malignant cells.. PubMed. 51(11). 2908–16. 305 indexed citations
14.
Berchuck, Andrew, George J. Olt, Andrew P. Soisson, et al.. (1990). Heterogeneity of antigen expression in advanced epithelial ovarian cancer. American Journal of Obstetrics and Gynecology. 162(4). 883–888. 22 indexed citations
15.
Boyer, Cinda M., Michael J. Borowitz, Kenneth S. McCarty, et al.. (1989). Heterogeneity of antigen expression in benign and malignant breast and ovarian epithelial cells. International Journal of Cancer. 43(1). 55–60. 23 indexed citations
16.
Ljung, Britt‐Marie, et al.. (1989). Cell dissociation techniques in human breast cancer — Variations in tumor cell viability and DNA ploidy. Breast Cancer Research and Treatment. 13(2). 153–159. 29 indexed citations
17.
Berchuck, Andrew, Andrew P. Soisson, Daniel L. Clarke‐Pearson, et al.. (1989). Immunohistochemical expression of CA 125 in endometrial adenocarcinoma: correlation of antigen expression with metastatic potential.. PubMed. 49(8). 2091–5. 36 indexed citations
18.
Takiguchi, Masafumi, et al.. (1985). Response of glioma cells to interferon‐gamma: increase in class II RNA, protein and mixed lymphocyte reaction‐stimulating ability. European Journal of Immunology. 15(8). 809–814. 62 indexed citations
19.
Boyer, Cinda M., John W. Kreider, & Gerald L. Bartlett. (1982). Regulation of the expression of adoptive tumor rejection immunity by recipient cyclophosphamide-sensitive cells.. PubMed. 42(6). 2211–5. 7 indexed citations
20.
Boyer, Cinda M., John W. Kreider, & Gerald L. Bartlett. (1981). Systemic adoptive transfer of immunity to 13762A rat mammary adenocarcinoma.. PubMed. 41(6). 2394–400. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Juan J. Roman Breakdown of academic impact, for papers by Ilana Yron Breakdown of academic impact, for papers by R. Vilella Breakdown of academic impact, for papers by Marialuisa Sensi Breakdown of academic impact, for papers by D J Panka Breakdown of academic impact, for papers by Ricciarda Galandrini Breakdown of academic impact, for papers by L M Neckers Breakdown of academic impact, for papers by Giuliana Papoff Breakdown of academic impact, for papers by Y Tsujimoto Breakdown of academic impact, for papers by Luigi Scotto
Rankless by CCL
2026